Current and Future Landscape of Immune Checkpoint Inhibitors in Urothelial Cancer.

O Alhalabi, AY Shah, EA Lemke… - Oncology (08909091 …, 2019 - search.ebscohost.com
Immune checkpoint inhibitors have revolutionized the field of oncology, providing a novel
mechanism for anticancer therapy. Programmed death 1--targeting antibodies …
被引用次数：14 相关文章

Current and Future Landscape of Immune Checkpoint Inhibitors in Urothelial Cancer

O Alhalabi, AY Shah, EA Lemke… - … (Williston Park, NY), 2019 - pubmed.ncbi.nlm.nih.gov
Immune checkpoint inhibitors have revolutionized the field of oncology, providing a novel
mechanism for anticancer therapy. Programmed death 1-targeting antibodies …

Current and Future Landscape of Immune Checkpoint Inhibitors in Urothelial Cancer.

O Alhalabi, AY Shah, EA Lemke… - Oncology (Williston Park …, 2019 - europepmc.org
Immune checkpoint inhibitors have revolutionized the field of oncology, providing a novel
mechanism for anticancer therapy. Programmed death 1-targeting antibodies …

Current and future landscape of immune checkpoint inhibitors in urothelial cancer

O Alhalabi, AY Shah, EA Lemke… - ONCOLOGY …, 2019 - mdanderson.elsevierpure.com
Immune checkpoint inhibitors have revolutionized the fi eld of oncology, providing a novel
mechanism for anticancer therapy. Programmed death 1 targeting antibodies …